 |
| ORGANIZING COMMITTEE/ INVITED SPEAKERS / SESSION CHAIRS
and SPONSORS
|
Joseph E. Tomaszewski, Ph.D., Deputy Director, Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute
(Co-chair, Organizing Committee)
|
James A. Crowell, Ph.D., D.A.B.T., Chief, Chemopreventive Agent Dev. Research Group, Division. of Cancer Prevention, National Cancer Institute
(Co-chair, Organizing Committee) |
Alexander Lyubimov, M.D. Ph.D., D.A.B.T., Director, Toxicology Research Laboratory, University of Illinois at Chicago
(Chair, Organizing Committee) |
| David Jacobson-Kram, Ph.D., Associate Director for Pharmacology and Toxicology, Center for Drug Evaluation and Research, US FDA |
| Bert W. Maidment, Ph.D., Associate Director, Product Development, NIAID/DAIT |
Judith A. Hewitt, Ph.D., Office of Biodefense Research Affairs, Division of Microbiology & Infectious Diseases, NIAID, Bethesda, MD |
Asrar B. Malik, Ph.D., Distinguished Professor and Head, Department of Pharmacology, University of Illinois at Chicago |
| Ronald D. Hood, Ph.D., Principal, Ronald D. Hood & Associates, Professor Emeritus of Biological Sciences, University of Alabama |
| Faith Davis, Ph.D., Professor, Division of Epidemiology and Biostatistics, University of Illinois at Chicago |
| Wanda M. Haschek-Hock, B.V.Sc., Ph.D., D.A.C.V.P., D.A.B.T., Professor of Pathobiology, University of Illinois Urbana-Champaign |
| Mark Hull, M.D., Ph.D., Professor, Leeds Institute of Molecular Medicine, Univ. of Leeds, St. James University Hospital, Leeds, UK |
| Thomas MacVittie, Ph.D ., Professor, University of Maryland, Baltimore |
| Eric Blomme, Ph.D., D.V.M., D.A.C.V.P., Abbott Laboratories, Chicago, Illinois |
| Mark Abdy, D.V.M., Ph.D., US Food and Drug Administration |
| William G. Nelson, M.D., Ph.D., Professor, John Hopkins University, Baltimore |
| Hajime Ohigashi, Ph.D., Graduate School of Agriculture, Kyoto University, Kyoto, Japan |
Young-Joon Surh, Ph.D., Chief & Professor, National Research Laboratory of Molecular Carcinogenesis and Chemoprevention, Seoul National University, Korea |
| Clarissa Gerhaeuser, Ph.D., German Cancer Research Center, Heidelberg, Germany |
| Moray Campbell, Ph.D., Institute of Biomedical Research, Medical School, University of Birmingham, United Kingdom |
| Caroline Lee,
Ph.D., Associate Professor, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore and Division of Medical Sciences, National Cancer Centre, Singapore |
| Raffaella Giavazzi, Ph.D., Head, Laboratory of Biology & Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy |
| Jean-Charles Soria, Ph.D., Division of Cancer Medicine, Institute Gustave Roussy, Paris France |
| Piet A. Van den Brandt, Ph.D., Nutrition and Toxicology Research Inst. Maastricht, Maastricht University, Maastricht, The Netherlands |
| Clive D. Morris, Ph.D., Medical Science Director Oncology, Astra Zeneca, UK |
| Melinda G. Hollingshead, D.V.M., Ph.D., Chief, NCI-FCRDC |
| Richard J. Hatchett, M.D., Associate Director, Radiation Countermeasures Research and Emergency Preparedness, NIAID/DAIT |
| David R. Casssatt, Ph.D., Program Officer, NIAID/DAIT |
| Beverly A. Teicher, Ph.D., Vice President, Oncology Research Genzyme Corporation, Framingham, MA |
| Angelika Burger, Ph.D., Director, Greenebaum Cancer Center, University of Maryland School of Medicine |
| Hasan Mukhtar, Ph.D., Vice-Chair and Director of Research, Department of Dermatology, Medical School, University of Wisconsin |
| Shivendra V. Singh, Ph.D., Professor, Cancer Center, University of Pittsburgh |
| Roderick H. Dashwood, Ph.D., Professor and Chief, Cancer Chemoprotection Program, Oregon State University |
| Rajesh Agarwal, Ph.D., Professor, School of Pharmacy, University of Colorado Health Sciences Center |
| Gary Stoner, Ph.D., College of Medicine and Public Health, Department of Internal Medicine, Ohio State University |
| Keith A. Rodvold, Pharm.D., Professor, Department of Pharmacy Practice, University of Illinois at Chicago |
| Fritz H. Schröder, Ph.D., Department of Urology, Erasmus MC, University Medical Center Rotterdam, The Netherlands |
| Dai Nakae, M.D., Ph.D., Head, Department of Pathology, Sasaki Institute, Sasaki Foundation, Japan |
| Gail S. Prins, Ph.D., Professor of Physiology, Department of Urology, University of Illinois at Chicago |
| Sanjay Gupta, Ph.D., Department of Urology, Case Western Reserve University, Cleveland, Ohio |
David Kerstin, Ph.D., Vice-President, Center for Cancer Research at the Israelitic Hospital, Hamburg, Germany |
| Michael A. White, Ph.D., Associate Professor, Department of Cell Biology, UT Southwestern Medical Center, Dallas, TX |
| Robert H Costa, Ph.D., Professor, Assistant Director of the GI Cancer Program, University of Illinois at Chicago |
| Myrtle Davis, D.V.M., Ph.D., Investigative Toxicology, Lilly Research Laboratories, Greenfield, IN |
Edward A. Sausville, M.D., Ph.D., F.A.C.P., Associate Director, Greenebaum Cancer Center, University of Maryland, Baltimore, MD |
| James A. Radosevich, Ph.D., Professor, Center for Molecular Biology of Oral Diseases, University of Illinois at Chicago |
| Richard Minshall, Ph.D., Assistant Professor of Pharmacology, University of Illinois at Chicago |
| Hayat Onyuksel, Ph.D., Professor of Pharmaceutics and Bioengineering, University of Illinois at Chicago |
| Vladimir Muzykantov, M.D., Ph.D., Director, Targeted Therapeutics Program, Institute of Translational Medicine & Therapeutics, University of PA |
SPONSORS:
TOXICOLOGY RESEARCH LABORATORY, DEPARTMENT OF PHARMACOLOGY AND CANCER CENTER, UNIVERSITY OF ILLINOIS AT CHICAGO
APPLIED BIOSYSTEMS
ELSEVIER
SOCIETY OF TOXICOLOGY
LABCAT
WATERS CORPORATION
HILLTOP LAB ANIMALS, INC. BRISTOL-MYERS SQUIBB
MARSHALL FARMS
THERMO ELECTRON NORTH AMERICA LLC
ANILYTICS, INC.
EMKA TECHNOLOGIES, INC.
PERKINELMER, LIFE & ANALYTICAL SCIENCES
|
Back to TOP
|
